- Home
- ATER vs COCP Comparison
ATER vs COCP Comparison
Compare ATER & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- COCP
- Stock Information
- Founded
- ATER 2014
- COCP 2006
- Country
- ATER United States
- COCP United States
- Employees
- ATER N/A
- COCP N/A
- Industry
- ATER Home Furnishings
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- COCP Health Care
- Exchange
- ATER Nasdaq
- COCP Nasdaq
- Market Cap
- ATER 15.5M
- COCP 15.4M
- IPO Year
- ATER N/A
- COCP N/A
- Fundamental
- Price
- ATER $1.36
- COCP $1.70
- Analyst Decision
- ATER
- COCP Strong Buy
- Analyst Count
- ATER 0
- COCP 1
- Target Price
- ATER N/A
- COCP $6.00
- AVG Volume (30 Days)
- ATER 251.1K
- COCP 24.3K
- Earning Date
- ATER 08-07-2025
- COCP 08-13-2025
- Dividend Yield
- ATER N/A
- COCP N/A
- EPS Growth
- ATER N/A
- COCP N/A
- EPS
- ATER N/A
- COCP N/A
- Revenue
- ATER $94,191,000.00
- COCP N/A
- Revenue This Year
- ATER N/A
- COCP N/A
- Revenue Next Year
- ATER $7.48
- COCP N/A
- P/E Ratio
- ATER N/A
- COCP N/A
- Revenue Growth
- ATER N/A
- COCP N/A
- 52 Week Low
- ATER $1.22
- COCP $1.12
- 52 Week High
- ATER $3.84
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- ATER 39.29
- COCP 60.02
- Support Level
- ATER $1.46
- COCP $1.46
- Resistance Level
- ATER $1.56
- COCP $1.95
- Average True Range (ATR)
- ATER 0.11
- COCP 0.10
- MACD
- ATER -0.01
- COCP 0.03
- Stochastic Oscillator
- ATER 4.21
- COCP 51.76
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).